approval
saveWEZLANA (USTEKINUMAB-AUUB) — FDA approval
community read0 votes
Sponsor: AMGEN INC. Form: INJECTABLE. Route: INTRAVENOUS, SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- approvalWEZLANA (USTEKINUMAB-AUUB) — FDA approvalSep 25, 2025 · 371d ago
- approvalWEZLANA (USTEKINUMAB-AUUB) — FDA approvalDec 26, 2024 · 644d ago
- approvalWEZLANA (USTEKINUMAB-AUUB) — FDA approvalDec 26, 2024 · 644d ago
- approvalWEZLANA (USTEKINUMAB-AUUB) — FDA approvalOct 31, 2023 · 1066d ago
- approvalWEZLANA (USTEKINUMAB-AUUB) — FDA approvalOct 31, 2023 · 1066d ago
same company · ±60 days · 6
- approvalWEZLANA: WEZLANA (USTEKINUMAB-AUUB) — FDA approvalSep 25, 2025
- approvaleculizumab biosimilar: BKEMV (ECULIZUMAB-AEEB) — FDA approvalSep 17, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalSep 17, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalOct 16, 2025
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalOct 21, 2025
- approvaltarlatamab: IMDELLTRA (TARLATAMAB-DLLE) — FDA approvalNov 19, 2025
comments(0)
5-min edit window · permanent after that